Moreover, functionalized hybrid hydrogels targeting cancer biomarkers like prostate-specific antigen (PSA) or carcinoembryonic antigen (CEA) have demonstrated potential for non-invasive cancer diagnostics. The gene discussed is KLK3; the disease is cancer.